Evidence map›Paper›PMID 40198236›Full record

Observational studyEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery2025

Implications of pacemaker implantation after aortic valve surgery for endocarditis: a nationwide study†.

Lisa O F Bearpark, Michael Dismorr, Anders Franco-Cereceda, Ulrik Sartipy, Natalie Glaser

Abstract readObservational Study
In one paragraph

Observational study in European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lisa O F BearparkDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-6951-8831
Michael DismorrDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Anders Franco-CerecedaDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-3427-9455
Ulrik SartipyDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-2707-0263
Natalie GlaserDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-4386-1041

Funding

Swedish Heart-Lung Foundation 20241040
6 · The paper itself

Abstract

objectivesInfective endocarditis (IE) is associated with a high risk of atrioventricular block and surgery adds to the risk of receiving a permanent pacemaker. The clinical impact of pacemaker implantation in IE patients is insufficiently studied. Our objective was to analyse long-term clinical outcomes in patients who receive a permanent pacemaker after IE surgery.

methodsWe conducted a nationwide observational cohort study, including all patients undergoing surgery for aortic valve IE in Sweden 1997-2022. The exposure group was patients who received a permanent pacemaker within 30 days of surgery. We used inverse probability of treatment weighting to account for inter-group differences and flexible parametric models to estimate hazards and cumulative incidences. Outcomes were all-cause mortality, heart failure and reinfection in the prosthetic valve.

resultsAmong 2175 patients who underwent surgery for aortic valve endocarditis, 168 (8%) received a permanent pacemaker. The mean age was 59 years; 18% were female. During a mean follow-up of 8.0 years (maximum 26 years), 822 patients (38%) died. At 15 years, the cumulative incidence of all-cause mortality was 60% versus 50% in the pacemaker versus the no pacemaker group; for heart failure, it was 21% versus 16%. We found no association of pacemaker implantation with mortality [hazard ratio (HR) 1.17; 95% confidence interval (CI) 0.86-1.58], heart failure (HR 1.42; 95% CI 0.89-2.29) or reinfection (HR 0.85; 95% CI 0.50-1.45).

conclusionsPacemaker implantation after surgery for aortic valve IE is common but was not associated with an increased risk of death, heart failure or reinfection. Although pacemaker need suggests more advanced disease, these results show that lifesaving surgery is not importantly jeopardised by the need for a pacemaker.

Indexed as

Aortic ValveEndocarditisHeart Valve Prosthesis ImplantationPacemaker, ArtificialPostoperative ComplicationsAgedFemaleHumansMaleMiddle AgedSwedenAortic valveEndocarditisLong-term survivalOutcomesPacemakerValve surgery

Identifiers

PMID40198236
PMCPMC12033029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.